000 | 01291 a2200361 4500 | ||
---|---|---|---|
005 | 20250515005711.0 | ||
264 | 0 | _c20051215 | |
008 | 200512s 0 0 eng d | ||
022 | _a1389-4501 | ||
024 | 7 |
_a10.2174/138945005774574498 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aStaehler, M | |
245 | 0 | 0 |
_aTargeted agents for the treatment of advanced renal cell carcinoma. _h[electronic resource] |
260 |
_bCurrent drug targets _cNov 2005 |
||
300 |
_a835-46 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAngiogenesis Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
650 | 0 | 4 |
_aBenzimidazoles _xadministration & dosage |
650 | 0 | 4 |
_aCarcinoma, Renal Cell _xdrug therapy |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aDrug Delivery Systems |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKidney Neoplasms _xdrug therapy |
650 | 0 | 4 |
_avon Hippel-Lindau Disease _xgenetics |
700 | 1 | _aRohrmann, K | |
700 | 1 | _aHaseke, N | |
700 | 1 | _aStief, C G | |
700 | 1 | _aSiebels, M | |
773 | 0 |
_tCurrent drug targets _gvol. 6 _gno. 7 _gp. 835-46 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2174/138945005774574498 _zAvailable from publisher's website |
999 |
_c15928785 _d15928785 |